Dette websted bruger cookies. Cookies hjælper os med at levere vores tjenester. Ved at bruge vores tjenester giver du dit samtykke til vores brug af cookies. Dine data er sikre hos os. Vi deler ingen af dine analyse- eller kontaktoplysninger med tredjeparter! Du kan finde flere oplysninger i Privatlivspolitik.
Subtitle "Afrikaans" was produced by machine.Subtitle "አማርኛ" was produced by machine.Subtitle "العربية " was produced by machine.Subtitle "Ārāmāyâ" was produced by machine.Subtitle "azərbaycan dili " was produced by machine.Subtitle "беларуская мова " was produced by machine.Подзаглавието "България" е създадено от машина.Subtitle "বাংলা " was produced by machine.Subtitle "བོད་ཡིག" was produced by machine.Subtitle "босански" was produced by machine.Subtitle "català" was produced by machine.Subtitle "Cebuano" was produced by machine.Subtitle "ગુજરાતી" was produced by machine.Subtitle "corsu" was produced by machine.Podtitul "Čeština" byl vytvořen automaticky.Subtitle "Cymraeg" was produced by machine.Subtitle "Dansk" was produced by machine.Untertitel "Deutsch" wurde maschinell erzeugt.Subtitle "Untertitel" was produced by machine.Subtitle "Ελληνικά" was produced by machine.Subtitle "English" was produced by machine.Subtitle "Esperanto" was produced by machine.El subtítulo "Español" se generó automáticamente.Subtitle "Eesti" was produced by machine.Subtitle "euskara" was produced by machine.Subtitle "فارسی" was produced by machine.Subtitle "Suomi" was produced by machine.Le sous-titre "Français" a été généré automatiquement.Subtitle "Frysk" was produced by machine.Subtitle "Gaeilge" was produced by machine.Subtitle "Gàidhlig" was produced by machine.Subtitle "Galego" was produced by machine.Subtitle "Schwizerdütsch" was produced by machine.Subtitle "هَوُسَ" was produced by machine.Subtitle "Ōlelo Hawaiʻi" was produced by machine.Subtitle "עברית" was produced by machine.Subtitle "हिन्दी" was produced by machine.Subtitle "Mẹo" was produced by machine.Subtitle "Hrvatski" was produced by machine.Subtitle "Kreyòl ayisyen " was produced by machine.Subtitle "Magyar" was produced by machine.Subtitle "Հայերեն" was produced by machine.Subtitle "Bahasa Indonesia " was produced by machine.Subtitle "Asụsụ Igbo " was produced by machine.Textun"Íslenska" var framkvæmt vélrænt.Sottotitoli "Italiano" sono stati generati automaticamente.Subtitle "日本語" was produced by machine.Subtitle "Basa Jawa" was produced by machine.Subtitle "ქართული" was produced by machine.Subtitle "қазақ тілі " was produced by machine.Subtitle "ភាសាខ្មែរ" was produced by machine.Subtitle "ಕನ್ನಡ" was produced by machine.Subtitle "한국어" was produced by machine.Subtitle "कोंकणी語" was produced by machine.Subtitle "کوردی" was produced by machine.Subtitle "Кыргызча" was produced by machine.Subtitle " lingua latina" was produced by machine.Subtitle "Lëtzebuergesch" was produced by machine.Subtitle "Lingala" was produced by machine.Subtitle "ພາສາ" was produced by machine.Subtitle "Lietuvių" was produced by machine.Subtitle "Latviešu" was produced by machine.Subtitle "fiteny malagasy" was produced by machine.Subtitle "te reo Māori" was produced by machine.Subtitle "македонски јазик" was produced by machine.Subtitle "malayāḷaṁ" was produced by machine.Subtitle "မြန်မာစာ " was produced by machine.Subtitle "Монгол хэл" was produced by machine.Subtitle "मराठी" was produced by machine.Subtitle "Bahasa Malaysia" was produced by machine.Subtitle "Malti" was produced by machine.Subtitle "ဗမာစာ " was produced by machine.Subtitle "नेपाली" was produced by machine.Subtitle "Nederlands" was produced by machine.Subtitle "Norsk" was produced by machine.Subtitle "chiCheŵa" was produced by machine.Subtitle "ਪੰਜਾਬੀ" was produced by machine.Subtitle "Polska" was produced by machine.Subtitle "پښتو" was produced by machine.Subtitle "Português" was produced by machine.Subtitle "Română" was produced by machine.Subtitle "Язык жестов (Русский)" was produced by machine.Субтитры "Pусский" были созданы машиной.Subtitle "Kinyarwanda" was produced by machine.Subtitle "सिन्धी" was produced by machine.Subtitle "Deutschschweizer Gebärdensprache" was produced by machine.Subtitle "සිංහල" was produced by machine.Subtitle "Slovensky" was produced by machine.Subtitle "Slovenski" was produced by machine.Subtitle "gagana fa'a Samoa" was produced by machine.Subtitle "chiShona" was produced by machine.Subtitle "Soomaaliga" was produced by machine.Subtitle "Shqip" was produced by machine.Subtitle "србски" was produced by machine.Subtitle "Sesotho" was produced by machine.Subtitle "Basa Sunda" was produced by machine.Undertext "Svenska" är maskinell skapad.Subtitle "Kiswahili" was produced by machine.Subtitle "தமிழ்" was produced by machine.Subtitle "తెలుగు" was produced by machine.Subtitle "Тоҷикй" was produced by machine.Subtitle "ภาษาไทย" was produced by machine.Subtitle "ትግርኛ" was produced by machine.Subtitle "Tagalog" was produced by machine.Subtitle "Türkçe" was produced by machine.Subtitle "татар теле" was produced by machine.Subtitle "Українська " was produced by machine.Subtitle "اردو" was produced by machine.Subtitle "Oʻzbek" was produced by machine.Subtitle "Tiếng Việt" was produced by machine.Subtitle "Serbšćina" was produced by machine.Subtitle "isiXhosa" was produced by machine.Subtitle "ייִדיש" was produced by machine.Subtitle "Yorùbá" was produced by machine.Subtitle "中文" was produced by machine.Subtitle "isiZulu" was produced by machine.
kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV не носи отговорност за некачествен превод.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV nenese žádnou odpovědnost za chybné překlady.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV übernimmt keine Haftung für mangelhafte Übersetzung.kla.TV accepts no liability for inadequate translationkla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV no se hace responsable de traducciones incorrectas.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV n'assume aucune responsabilité en cas de mauvaise traduction.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV nem vállal felelősséget a hibás fordításértkla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV tekur enga ábyrgð á áræðanleika þýðingarinnarKla.TV non si assume alcuna responsabilità per traduzioni lacunose e/o errate.Kla.TV は、不適切な翻訳に対して一切の責任を負いません。kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV не несет ответственности за некачественный перевод.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.Kla.TV tar inget ansvar för felaktiga översättningar.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.
BioNTech: Covid 19 forudgående viden, forudgående finansiering og krisegevinst
Medicinalvirksomheden BioNTech har haft en meteorisk fremgang i branchen i 2021, og dens navn er kendt over hele verden. Selv om virksomheden stadig havde et tab på 181 millioner euro i 2019, blev der forventet et overskud på mindst ni milliarder euro i 2021. Så er det ikke interessant at se nærmere på deres opskrift på succes? Hvem vil ikke gerne stige lige så meteorisk op? [læs mere]
[Læs mere]
BioNTech: Covid 19 forudgående viden, forudgående finansiering og krisegevinst
Medicinalvirksomheden BioNTech har haft en meteorisk fremgang i branchen i 2021, og dens navn er kendt over hele verden.
Mens virksomheden stadig havde et underskud på 181 millioner euro i 2019, var der forventet et overskud på mindst ni milliarder euro i 2021.
Er det ikke interessant at se nærmere på deres koncept for succes?
For hvem ville ikke gerne stige lige så meteorisk?
I BioNTech`s offentligt tilgængelige årsrapport 2019, under ”Active ingredient class:
mRNA” under produktnavnet ”BNT162”, kan indikationen ”COVID-19” findes.
Det betyder, at vaccinen til behandling af COVID-19 skulle være klar allerede i 2017 eller senest ved udgangen af 2018.
For på tidspunktet for årsberetningen var den prækliniske testfase og endda halvdelen af testfase 1 allerede helt afsluttet.
En managementkonsulent spurgte derfor ledelsen i BioNTech:
”Hvordan var din virksomhed i stand til at udvikle et terapeutisk middel, som allerede havde afsluttet prækliniske test i slutningen af 2019, når virussen ikke engang dukkede op før december 2019?”
- Hun modtog aldrig noget svar.
- Senere indrømmede administrerende direktør Türeci modvilligt over for pressen, at hun var blevet informeret på forhånd.
Hvis BioNTech allerede forskede i en vaccine mod en sygdom, der endnu ikke eksisterede, hvad betyder det så andet end at pandemien var planlagt på lang sigt?!
Det er værd at se nærmere på dette. Hvor kom den forudgående viden fra?
Hvert år finder verdenstopmødet om sundhed (WHS*) sted i Berlin.
I oktober 2018 mødtes bl.a. Angela Merkel, Bill Gates, Norges statsminister, WHO-direktøren og den indtil da stort set ukendte og økonomisk mislykkede BioNTech-iværksætter ved navn Uğur Şahin der.
Det var først i august 2018, at BioNTech underskrev en kontrakt med Pfizer om at udvikle mRNA-baserede vacciner til forebyggelse af influenza.
Pfizer investerede 305 millioner amerikanske dollars i 2018, dvs. på et tidspunkt, hvor BioNTech endnu ikke havde haft nogen succes.
Bill & Melinda Gates Foundation er den største bidragyder til Det Forenede Kongeriges reguleringsorgan for lægemidler og sundhedsprodukter (MHRA).
I september 2019, lige før udbruddet af Covid 19-pandemien, købte denne fond BioNTech-aktier til en værdi af 55 millioner dollars.
Den Europæiske Investeringsbank (EIB) sikrede også 50 millioner euro til BioNTech.
”Den eneste vaccine, der, hvis alt går perfekt, kan blive godkendt til akut brug inden udgangen af oktober (2020), ville være Pfizer,” sagde Bill Gates dengang.
Det er interessant, at den Gates-finansierede MHRA forlængede nødgodkendelsen af Pfizer/BioNTechs mRNA-vaccine i Det Forenede Kongerige, så den kan gives til børn i alderen 12-15 år fra den 4. juni 2021.
Hvem er stadig overrasket over BioNTech's meteoriske fremgang?
Før pandemien, dvs. i 2019, det år med de største tab til dato, forhøjede BioNTech lønningerne til bestyrelses- og tilsynsrådsmedlemmerne, i nogle tilfælde med næsten 1.000 %.
Udtrykt i tal:
Den tidligere årsløn til administrerende direktør Şahin blev forhøjet fra 653.000 EUR til 7.000.064 EUR.
Disse finansmænds investering i en virksomhed, der allerede havde været stærkt forgældet i årevis, samt den utrolige lønstigning tyder på, at de involverede helt sikkert vidste, at der snart var milliardgevinster i vente.
Endnu en brik i det puslespil, der afslører pandemien, som først blev erklæret i marts 2020, som en planemisk sygdom, hvor Bill Gates er en afgørende nøgleperson.
En planemie er en forud planlagt, kunstigt fremkaldt krise, hvor planlæggerne og investorerne tjener sig selv til grin i optakten til krisen.
På bekostning af den brede offentlighed, naturligvis.
Burde der ikke stå: Penge tilbage!
Og burde man ikke principielt forbyde kriseprofit, dvs. at tjene en formue på kriser, for at kvæle sådanne kriminelle forretningsmodeller i opløbet?
26.04.2022 | www.kla.tv/22361
BioNTech: Covid 19 forudgående viden, forudgående finansiering og krisegevinst Medicinalvirksomheden BioNTech har haft en meteorisk fremgang i branchen i 2021, og dens navn er kendt over hele verden. Mens virksomheden stadig havde et underskud på 181 millioner euro i 2019, var der forventet et overskud på mindst ni milliarder euro i 2021. Er det ikke interessant at se nærmere på deres koncept for succes? For hvem ville ikke gerne stige lige så meteorisk? I BioNTech`s offentligt tilgængelige årsrapport 2019, under ”Active ingredient class: mRNA” under produktnavnet ”BNT162”, kan indikationen ”COVID-19” findes. Det betyder, at vaccinen til behandling af COVID-19 skulle være klar allerede i 2017 eller senest ved udgangen af 2018. For på tidspunktet for årsberetningen var den prækliniske testfase og endda halvdelen af testfase 1 allerede helt afsluttet. En managementkonsulent spurgte derfor ledelsen i BioNTech: ”Hvordan var din virksomhed i stand til at udvikle et terapeutisk middel, som allerede havde afsluttet prækliniske test i slutningen af 2019, når virussen ikke engang dukkede op før december 2019?” - Hun modtog aldrig noget svar. - Senere indrømmede administrerende direktør Türeci modvilligt over for pressen, at hun var blevet informeret på forhånd. Hvis BioNTech allerede forskede i en vaccine mod en sygdom, der endnu ikke eksisterede, hvad betyder det så andet end at pandemien var planlagt på lang sigt?! Det er værd at se nærmere på dette. Hvor kom den forudgående viden fra? Hvert år finder verdenstopmødet om sundhed (WHS*) sted i Berlin. I oktober 2018 mødtes bl.a. Angela Merkel, Bill Gates, Norges statsminister, WHO-direktøren og den indtil da stort set ukendte og økonomisk mislykkede BioNTech-iværksætter ved navn Uğur Şahin der. Det var først i august 2018, at BioNTech underskrev en kontrakt med Pfizer om at udvikle mRNA-baserede vacciner til forebyggelse af influenza. Pfizer investerede 305 millioner amerikanske dollars i 2018, dvs. på et tidspunkt, hvor BioNTech endnu ikke havde haft nogen succes. Bill & Melinda Gates Foundation er den største bidragyder til Det Forenede Kongeriges reguleringsorgan for lægemidler og sundhedsprodukter (MHRA). I september 2019, lige før udbruddet af Covid 19-pandemien, købte denne fond BioNTech-aktier til en værdi af 55 millioner dollars. Den Europæiske Investeringsbank (EIB) sikrede også 50 millioner euro til BioNTech. ”Den eneste vaccine, der, hvis alt går perfekt, kan blive godkendt til akut brug inden udgangen af oktober (2020), ville være Pfizer,” sagde Bill Gates dengang. Det er interessant, at den Gates-finansierede MHRA forlængede nødgodkendelsen af Pfizer/BioNTechs mRNA-vaccine i Det Forenede Kongerige, så den kan gives til børn i alderen 12-15 år fra den 4. juni 2021. Hvem er stadig overrasket over BioNTech's meteoriske fremgang? Før pandemien, dvs. i 2019, det år med de største tab til dato, forhøjede BioNTech lønningerne til bestyrelses- og tilsynsrådsmedlemmerne, i nogle tilfælde med næsten 1.000 %. Udtrykt i tal: Den tidligere årsløn til administrerende direktør Şahin blev forhøjet fra 653.000 EUR til 7.000.064 EUR. Disse finansmænds investering i en virksomhed, der allerede havde været stærkt forgældet i årevis, samt den utrolige lønstigning tyder på, at de involverede helt sikkert vidste, at der snart var milliardgevinster i vente. Endnu en brik i det puslespil, der afslører pandemien, som først blev erklæret i marts 2020, som en planemisk sygdom, hvor Bill Gates er en afgørende nøgleperson. En planemie er en forud planlagt, kunstigt fremkaldt krise, hvor planlæggerne og investorerne tjener sig selv til grin i optakten til krisen. På bekostning af den brede offentlighed, naturligvis. Burde der ikke stå: Penge tilbage! Og burde man ikke principielt forbyde kriseprofit, dvs. at tjene en formue på kriser, for at kvæle sådanne kriminelle forretningsmodeller i opløbet?
Fra bri; ew; mbo; nis; hm
Pandemisk forhåndskendskab hos BioNTech https://bit.ly/3rRgdvG
https://bit.ly/3sO5mSf
Pandemidrivere mødes allerede i 2018 med BioNTech https://report24.news/merkel-gates-sahin-dubioses-treffen-der-pandemie-treiber-schon-2018/
Bill Gates - finansmand for MHRA og BioNTech https://queged.wordpress.com/2021/08/12/bill-gates-ist-der-wichtigste-geldgeber-der-mhra-und-besitzt-grose-anteile-an-pfizer-und-biontech-ist-es-da-ein-wunder-dass-die-mhra-den-impfstoff-fur-kinder-zugelassen-hat/
https://dailyexpose.uk/2021/05/30/shocking-86-of-children-suffered-an-adverse-reaction-to-the-pfizer-covid-vaccine-in-clinical-trial/